Schaper Benz & Wise Investment Counsel Inc. WI Buys 1,114 Shares of Align Technology, Inc. (NASDAQ:ALGN)

Schaper Benz & Wise Investment Counsel Inc. WI increased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,379 shares of the medical equipment provider’s stock after acquiring an additional 1,114 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI owned about 0.05% of Align Technology worth $8,419,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of ALGN. Impax Asset Management Group plc lifted its stake in shares of Align Technology by 26.8% in the 3rd quarter. Impax Asset Management Group plc now owns 114,057 shares of the medical equipment provider’s stock valued at $29,007,000 after acquiring an additional 24,115 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Align Technology by 2.7% in the 3rd quarter. Principal Financial Group Inc. now owns 82,020 shares of the medical equipment provider’s stock valued at $20,859,000 after acquiring an additional 2,168 shares during the last quarter. Kornitzer Capital Management Inc. KS bought a new stake in shares of Align Technology in the 3rd quarter valued at about $205,000. Portside Wealth Group LLC bought a new stake in shares of Align Technology in the 3rd quarter valued at about $238,000. Finally, ARK Investment Management LLC lifted its stake in shares of Align Technology by 5.3% in the 3rd quarter. ARK Investment Management LLC now owns 6,413 shares of the medical equipment provider’s stock valued at $1,631,000 after acquiring an additional 322 shares during the last quarter. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Up 1.0 %

Align Technology stock opened at $173.75 on Friday. The company has a market capitalization of $12.79 billion, a P/E ratio of 30.97, a PEG ratio of 2.24 and a beta of 1.69. The stock’s 50 day moving average is $208.02 and its 200 day moving average is $221.29. Align Technology, Inc. has a twelve month low of $167.32 and a twelve month high of $335.40.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a return on equity of 13.84% and a net margin of 10.54%. As a group, equities analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Wall Street Analysts Forecast Growth

ALGN has been the subject of a number of recent analyst reports. Leerink Partnrs raised Align Technology from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 6th. Piper Sandler lowered their price target on Align Technology from $275.00 to $270.00 and set an “overweight” rating for the company in a research report on Thursday, February 6th. Morgan Stanley lowered their price target on Align Technology from $280.00 to $272.00 and set an “overweight” rating for the company in a research report on Thursday, February 6th. Mizuho initiated coverage on Align Technology in a research report on Wednesday, December 4th. They set an “outperform” rating and a $295.00 price target for the company. Finally, Bank of America upped their price target on Align Technology from $200.00 to $206.00 and gave the company an “underperform” rating in a research report on Friday, December 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $269.91.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.